FDA
approval
· 2022-12-29
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)
Summary
The FDA approved a supplemental application for the generic fixed-dose combination of olmesartan medoxomil and hydrochlorothiazide from Solco Healthcare US, LLC…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)